It took Barney Graham, Jason Mclellan and their collaborators just a weekend in January 2020 to design a novel vaccine they believed would be capable of protecting people against COVID-19. Their design formed the basis for the vaccines that Moderna, Pfizer and others would eventually use to inoculate millions of Americans a little more than a year later, a pace of development unprecedented in the annals of modern medicine.
By then, however, the two pioneering virologists were already thinking about future pandemics— and how they might get ahead of them.
Graham and McLellan are part of a corps of researchers hoping to take the technology they used on COVID-19 vaccines and apply them to an even more futuristic creation: an arsenal of off-the-shelf premade vaccines that could be easily modified to attack new pathogens as they arise—a kind of “pan” or “universal” coronavirus vaccine capable of protecting against many different strains of the virus at the same time.
Even as scientists race to develop booster shots and tweak existing vaccines to work against new variants to SARS2, they’re looking ahead to future pandemics caused by entirely new pathogens from the same coronavirus family, one of just 26 known to infect humans. But SARS-CoV-2 is the third novel, deadly coronavirus to cross over from animals to humans in the last 20 years, and many scientists warn more will inevitably follow. Even though a “universal” vaccine that can protect against any new coronavirus that nature throws at us probably won’t be available this year or next, development has become a high priority.
Diese Geschichte stammt aus der May 21 - 28, 2021 (Double Issue)-Ausgabe von Newsweek.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der May 21 - 28, 2021 (Double Issue)-Ausgabe von Newsweek.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Most Loved Workplaces 2024
A THE WORLD'S MOST LOVED WORKPLACES ARE REMARKABLE FOR A variety of reasons.
Maya Hawke
MAYA HAWKE WEARS MANY HATS: ACTOR, WRITER, SINGER. BUT FOR Hawke, everything comes down to words.
Jacob Anderson
ANNE RICE'S NOVEL INTERVIEW WITH THE Vampire has a rabid fan base, intensely protective of the story and any adaptations of it.
VOTES OF NO CONFIDENCE
Why recent U.K. election results will ring alarm bells for Joe Biden
BIDEN'S BATTLEGROUND ELECTION
A small number of Democrats PROTESTING the president's support for Israel's war in Gaza could PREVENT him from winning a second term
'It's Time to Treat Addiction Like Cancer'
Both are serious illnesses but, unlike those struggling with substance use disorders, didn’t face shame and stigma when seeking help over my tumors
Could Influencers Survive a Tik Tok Ban?
With some content creators able to make good money from views and brand collaborations on the app, losing access to it could come ata high price
All Welcome, Except Some
A Chinese foreign agent is behind an Asian American parade in New York City with Mayor Eric Adams, but not everyone is invited
America's Maternity Hospitals 2024
The arrival of a healthy baby brings unparalleled joy. It's no wonder that families welcoming their newest members are looking for high-quality health care to ensure a smooth delivery and reliable postpartum care.
THE WEST SHOULD EXERT EVERY EFFORT TO MAKE RUSSIA PAY THE HIGHEST PRICE POSSIBLE FOR ITS AGGRESSIVE BEHAVIOR
RUSSIA'S FULL-SCALE INVASION of Ukraine in February 2022 awakened the worst memories for Georgians.